J. Á. García Sáenz

Exemestane versus anastrozole as front‐line endocrine therapy in postmenopausal patients with hormone receptor‐positive, advanced breast cancer

A. Ruíz, R. Andrés, A. Llombart-Cussac, 2012, Cancer.

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

P. Neven, A. Bardia, F. Bidard, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study

Alfonso Lopez de Sá, A. M. de Luna Aguilar, Paloma Flores Navarro, 2023, Cancers.

Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review

J. G. García Sáenz, J. Bobokova, E. Díaz-Rubio García, 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Assessment of Topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization.

C. Perou, Xiaping He, M. Cheang, 2011, The American journal of pathology.